DE602005027246D1 - Mittel zur linderung von niereninsuffizienz - Google Patents

Mittel zur linderung von niereninsuffizienz

Info

Publication number
DE602005027246D1
DE602005027246D1 DE602005027246T DE602005027246T DE602005027246D1 DE 602005027246 D1 DE602005027246 D1 DE 602005027246D1 DE 602005027246 T DE602005027246 T DE 602005027246T DE 602005027246 T DE602005027246 T DE 602005027246T DE 602005027246 D1 DE602005027246 D1 DE 602005027246D1
Authority
DE
Germany
Prior art keywords
niereninsuffizienz
reduction
linear
carbon atoms
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005027246T
Other languages
English (en)
Inventor
Keisuke Sato
Motoaki Saito
Bang Luu
Masashi Yamada
Hiroto Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Dairies Corp
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Publication of DE602005027246D1 publication Critical patent/DE602005027246D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602005027246T 2004-11-25 2005-11-25 Mittel zur linderung von niereninsuffizienz Active DE602005027246D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004341019 2004-11-25
PCT/JP2005/021705 WO2006057346A1 (ja) 2004-11-25 2005-11-25 腎機能障害改善剤

Publications (1)

Publication Number Publication Date
DE602005027246D1 true DE602005027246D1 (de) 2011-05-12

Family

ID=36498079

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005027246T Active DE602005027246D1 (de) 2004-11-25 2005-11-25 Mittel zur linderung von niereninsuffizienz

Country Status (10)

Country Link
US (2) US20080125495A1 (de)
EP (1) EP1829536B1 (de)
JP (1) JP4869078B2 (de)
KR (1) KR101169633B1 (de)
CN (1) CN101065119B (de)
AT (1) ATE503471T1 (de)
CA (1) CA2589252C (de)
DE (1) DE602005027246D1 (de)
ES (1) ES2361847T3 (de)
WO (1) WO2006057346A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006126295A1 (ja) * 2005-05-26 2006-11-30 Meiji Dairies Corporation 糖尿病性血管障害および呼吸障害予防および／または治療剤
JP4986505B2 (ja) * 2005-05-26 2012-07-25 株式会社明治 糖尿病性血管障害および呼吸障害予防および／または治療剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5697223A (en) * 1979-12-30 1981-08-05 Takeda Chem Ind Ltd Tissue metabolism activator
IL140069A0 (en) * 1998-06-11 2002-02-10 Fox Chase Cancer Ct A method for assessing a diabetic's risk of experiencing a diabetes-associated pathologic condition
JP2000083623A (ja) * 1998-09-10 2000-03-28 Nobuko Koga 食 品
JP4469441B2 (ja) * 1999-02-10 2010-05-26 明治乳業株式会社 神経変性疾患の予防又は治療薬
EP1322748B1 (de) * 2000-10-04 2009-12-02 Meiji Dairies Corporation Stemzelldifferenzierung induzierende promoter
JP3836684B2 (ja) 2001-02-19 2006-10-25 明治乳業株式会社 排尿障害治療剤
JP4861560B2 (ja) * 2001-02-19 2012-01-25 株式会社明治 糖尿病合併症治療剤
JP2004000115A (ja) * 2001-09-07 2004-01-08 Mitsuo Itakura 糖尿病の発症危険性判定方法

Also Published As

Publication number Publication date
EP1829536A1 (de) 2007-09-05
CN101065119B (zh) 2010-08-25
JPWO2006057346A1 (ja) 2008-06-05
US20120136068A1 (en) 2012-05-31
CA2589252A1 (en) 2006-06-01
EP1829536B1 (de) 2011-03-30
CN101065119A (zh) 2007-10-31
ES2361847T3 (es) 2011-06-22
WO2006057346A1 (ja) 2006-06-01
US20080125495A1 (en) 2008-05-29
ATE503471T1 (de) 2011-04-15
CA2589252C (en) 2012-12-04
EP1829536A4 (de) 2009-08-12
KR20070089922A (ko) 2007-09-04
JP4869078B2 (ja) 2012-02-01
KR101169633B1 (ko) 2012-07-31

Similar Documents

Publication Publication Date Title
EA200870321A1 (ru) Способ получения 4-оксохинолинового соединения
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
ATE312100T1 (de) Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten
BRPI0409949A (pt) compostos de pirazol amida aril-substituìda úteis como inibidores de cinase
ATE503746T1 (de) Neue imidazolidinderivate
HK1139381A1 (en) Bicyclic -amino acid derivative
MX2009010846A (es) Proceso para producir compuesto pesticidas de benzamidas.
DE60301345D1 (de) Stabilisierte askorbinsäurederivate
BR0013251A (pt) Derivado de isoxazolina e herbicida que contém o mesmo como ingrediente ativo
TW200640885A (en) Novel haoalkanesulfonylaniline derivatives, weed killer and the use methods thereof
TW200600971A (en) Calixresorcinarene compounds, photoresist base materials, and compositions thereof
MY146042A (en) Water-soluble benzoazepine compound and its pharmaceutical composition
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
ATE480527T1 (de) Thiadiazolinderivate zur krebsbehandlung
DE602005027246D1 (de) Mittel zur linderung von niereninsuffizienz
DE60216239T8 (de) Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie
TW200600013A (en) 5,6-Dialkyl-7-aminotriazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds
MX2022002898A (es) Compuesto de 7-oxa-3,4-diazabiciclo-[4.1.0]-4-hepten-2-ona y herbicida.
BRPI0511824A (pt) radiossensibilizador
MY144456A (en) Pesticidal agents on the basis of 1-aryl-aminopyrrol
EA200200682A1 (ru) Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие
MXPA03008725A (es) Medicamentos para hiperactividad vesicular.
PL1610785T3 (pl) Połączenie farmaceutyczne do leczenia spastyczności i/lub bólu
WO2008146691A1 (ja) 肝炎の予防又は治療のための医薬組成物
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament

Legal Events

Date Code Title Description
R082 Change of representative

Ref document number: 1829536

Country of ref document: EP

Representative=s name: HOFFMANN & EITLE, 81925 MUENCHEN, DE

R082 Change of representative

Ref document number: 1829536

Country of ref document: EP

Representative=s name: HOFFMANN - EITLE, DE